Literature DB >> 34475201

The Akt-mTOR Pathway Drives Myelin Sheath Growth by Regulating Cap-Dependent Translation.

Karlie N Fedder-Semmes1,2, Bruce Appel3,4.   

Abstract

In the vertebrate CNS, oligodendrocytes produce myelin, a specialized membrane, to insulate and support axons. Individual oligodendrocytes wrap multiple axons with myelin sheaths of variable lengths and thicknesses. Myelin grows at the distal ends of oligodendrocyte processes, and multiple lines of work have provided evidence that mRNAs and RNA binding proteins localize to myelin, together supporting a model where local translation controls myelin sheath growth. What signal transduction mechanisms could control this? One strong candidate is the Akt-mTOR pathway, a major cellular signaling hub that coordinates transcription, translation, metabolism, and cytoskeletal organization. Here, using zebrafish as a model system, we found that Akt-mTOR signaling promotes myelin sheath growth and stability during development. Through cell-specific manipulations to oligodendrocytes, we show that the Akt-mTOR pathway drives cap-dependent translation to promote myelination and that restoration of cap-dependent translation is sufficient to rescue myelin deficits in mTOR loss-of-function animals. Moreover, an mTOR-dependent translational regulator was phosphorylated and colocalized with mRNA encoding a canonically myelin-translated protein in vivo, and bioinformatic investigation revealed numerous putative translational targets in the myelin transcriptome. Together, these data raise the possibility that Akt-mTOR signaling in nascent myelin sheaths promotes sheath growth via translation of myelin-resident mRNAs during development.SIGNIFICANCE STATEMENT In the brain and spinal cord, oligodendrocytes extend processes that tightly wrap axons with myelin, a protein- and lipid-rich membrane that increases electrical impulses and provides trophic support. Myelin membrane grows dramatically following initial axon wrapping in a process that demands protein and lipid synthesis. How protein and lipid synthesis is coordinated with the need for myelin to be generated in certain locations remains unknown. Our study reveals that the Akt-mTOR signaling pathway promotes myelin sheath growth by regulating protein translation. Because we found translational regulators of the Akt-mTOR pathway in myelin, our data raise the possibility that Akt-mTOR activity regulates translation in myelin sheaths to deliver myelin on demand to the places it is needed.
Copyright © 2021 the authors.

Entities:  

Keywords:  mTOR; myelin; oligodendrocyte; zebrafish

Mesh:

Substances:

Year:  2021        PMID: 34475201      PMCID: PMC8513705          DOI: 10.1523/JNEUROSCI.0783-21.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

1.  Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.

Authors:  Rafael G Almeida; Tim Czopka; Charles Ffrench-Constant; David A Lyons
Journal:  Development       Date:  2011-08-31       Impact factor: 6.868

2.  Microtubule organization and stability in the oligodendrocyte.

Authors:  K F Lunn; P W Baas; I D Duncan
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

3.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.

Authors:  A C Gingras; S P Gygi; B Raught; R D Polakiewicz; R T Abraham; M F Hoekstra; R Aebersold; N Sonenberg
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

Review 4.  The race to decipher the top secrets of TOP mRNAs.

Authors:  Oded Meyuhas; Tamar Kahan
Journal:  Biochim Biophys Acta       Date:  2014-09-16

5.  Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.

Authors:  Emily P Harrington; Chao Zhao; Stephen P J Fancy; Sovann Kaing; Robin J M Franklin; David H Rowitch
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

6.  FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.

Authors:  Jian-Hua Mao; Il-Jin Kim; Di Wu; Joan Climent; Hio Chung Kang; Reyno DelRosario; Allan Balmain
Journal:  Science       Date:  2008-09-12       Impact factor: 47.728

7.  Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.

Authors:  Frédéric Lebrun-Julien; Lea Bachmann; Camilla Norrmén; Martin Trötzmüller; Harald Köfeler; Markus A Rüegg; Michael N Hall; Ueli Suter
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

8.  PAK1 Positively Regulates Oligodendrocyte Morphology and Myelination.

Authors:  Tanya L Brown; Hirokazu Hashimoto; Lisbet T Finseth; Teresa L Wood; Wendy B Macklin
Journal:  J Neurosci       Date:  2021-01-21       Impact factor: 6.709

9.  Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes.

Authors:  Iben Lundgaard; Aryna Luzhynskaya; John H Stockley; Zhen Wang; Kimberley A Evans; Matthew Swire; Katrin Volbracht; Hélène O B Gautier; Robin J M Franklin; David Attwell; Ragnhildur T Káradóttir
Journal:  PLoS Biol       Date:  2013-12-31       Impact factor: 8.029

10.  Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue.

Authors:  Nicolas Snaidero; Wiebke Möbius; Tim Czopka; Liesbeth H P Hekking; Cliff Mathisen; Dick Verkleij; Sandra Goebbels; Julia Edgar; Doron Merkler; David A Lyons; Klaus-Armin Nave; Mikael Simons
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

View more
  3 in total

Review 1.  Quercetin Can Improve Spinal Cord Injury by Regulating the mTOR Signaling Pathway.

Authors:  Xichen Wang; Yuke Fu; Benson O A Botchway; Yufeng Zhang; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

Review 2.  Evolutionary Origins of the Oligodendrocyte Cell Type and Adaptive Myelination.

Authors:  Jacob H Hines
Journal:  Front Neurosci       Date:  2021-12-01       Impact factor: 4.677

3.  Clemastine Induces an Impairment in Developmental Myelination.

Authors:  Ana Palma; Juan Carlos Chara; Alejandro Montilla; Amaia Otxoa-de-Amezaga; Francisca Ruíz-Jaén; Anna M Planas; Carlos Matute; Alberto Pérez-Samartín; María Domercq
Journal:  Front Cell Dev Biol       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.